Literature DB >> 14999689

Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.

Gaetano Serviddio1, Javier Pereda, Federico V Pallardó, Julian Carretero, Consuelo Borras, Juan Cutrin, Gianluigi Vendemiale, Giuseppe Poli, José Viña, Juan Sastre.   

Abstract

Ursodeoxycholic acid (UDCA) improves clinical and biochemical indices in primary biliary cirrhosis and prolongs survival free of liver transplantation. Recently, it was suggested that the cytoprotective mechanisms of UDCA may be mediated by protection against oxidative stress, which is involved in the development of cirrhosis induced by chronic cholestasis. The aims of the current study were 1) to identify the mechanisms involved in glutathione depletion, oxidative stress, and mitochondrial impairment during biliary cirrhosis induced by chronic cholestasis in rats; and 2) to determine the mechanisms associated with the protective effects of UDCA against secondary biliary cirrhosis. The findings of the current study indicate that UDCA partially prevents hepatic and mitochondrial glutathione depletion and oxidation resulting from chronic cholestasis. Impairment of biliary excretion was accompanied by decreased steady-state hepatic levels of gamma-glutamyl cysteine synthetase and gamma-cystathionase messenger RNAs. UDCA treatment led to up-regulation of gamma-glutamyl cysteine synthetase in animals with secondary biliary cirrhosis and prevented the marked increases in mitochondrial peroxide production and hydroxynonenal-protein adduct production that are observed during chronic cholestasis. A population of damaged and primarily apoptotic hepatocytes characterized by dramatic decreases in mitochondrial cardiolipin levels and membrane potential as well as phosphatidylserine exposure evolves in secondary biliary cirrhosis. UDCA treatment prevents the growth of this population along with the decreases in mitochondrial cardiolipin levels and membrane potential that are induced by chronic cholestasis. In conclusion, UDCA treatment enhances the antioxidant defense mediated by glutathione; in doing so, this treatment prevents cardiolipin depletion and cell injury in animals with secondary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999689     DOI: 10.1002/hep.20101

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  37 in total

1.  The Effect of NeuroAid (MLC901) on Cholestasis-Induced Spatial Memory Impairment with Respect to the Expression of BAX, BCL-2, BAD, PGC-1α and TFAM Genes in the Hippocampus of Male Wistar Rats.

Authors:  Pejman Molaei; Salar Vaseghi; Maliheh Entezari; Mehrdad Hashemi; Mohammad Nasehi
Journal:  Neurochem Res       Date:  2021-05-24       Impact factor: 3.996

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

3.  Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats.

Authors:  Serhat Oguz; Mehmet Kanter; Mustafa Erboga; Cengiz Erenoglu
Journal:  J Mol Histol       Date:  2012-01-21       Impact factor: 2.611

4.  Effects of total glucosides of peony on immunological hepatic fibrosis in rats.

Authors:  Hua Wang; Wei Wei; Ni-Ping Wang; Cheng-Yi Wu; Shang-Xue Yan; Li Yue; Ling-Ling Zhang; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 5.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

7.  Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.

Authors:  Mohammad Nasehi; Sepehr Torabinejad; Mehrdad Hashemi; Salar Vaseghi; Mohammad-Reza Zarrindast
Journal:  Metab Brain Dis       Date:  2019-11-26       Impact factor: 3.584

8.  Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.

Authors:  Göksel Sener; A Ozer Sehirli; Hale Z Toklu; Meral Yuksel; Feriha Ercan; Nursal Gedik
Journal:  Pediatr Surg Int       Date:  2007-01-10       Impact factor: 1.827

9.  Decreasing mitochondrial fission prevents cholestatic liver injury.

Authors:  Tianzheng Yu; Li Wang; Hakjoo Lee; Dawn K O'Brien; Steven F Bronk; Gregory J Gores; Yisang Yoon
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

Review 10.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.